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Susanne Fischer* and Urs M NaterAbstract
Background: The diagnosis of functional somatic syndromes (FSS) requires 1) presence of somatic symptoms, and 2)
absence of medical conditions potentially accounting for these symptoms. Due to the limited feasibility of medical
examinations, epidemiological research on FSS has neglected to assess the second criterion. Our objective was
therefore to evaluate the implications of considering information on exclusionary medical conditions in
epidemiological research on FSS.
Methods: A survey among 3’054 students was conducted. We compared prevalence rates and overlap of 17 FSS
obtained by: 1) a symptom-based strategy and 2) a symptom-and-exclusion-based strategy including information on
exclusionary medical conditions.
Results: The symptom-and-exclusion-based strategy led to a marked decrease in prevalence rates compared to the
symptom-based strategy. Furthermore, it resulted in fewer individuals who were affected by multiple FSS.
Conclusions: Adding self-reported information on exclusionary medical conditions leads to a significant decrease in
the prevalence and overlap of FSS. More rigorous approaches to studying FSS should be adopted.
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The term ‘functional somatic syndrome’ (FSS) refers to a
certain constellation of somatic symptoms that cannot be
adequately explained in the context of a known medical
condition. Case definitions of the numerous existing FSS
therefore each require 1) the presence of at least one char-
acteristic symptom (positive criterion), and 2) the absence
of any medical condition that can account for these symp-
toms (negative criterion). There is a long list of FSS, but
among the most prevalent are chronic fatigue syndrome,
fibromyalgia syndrome, and irritable bowel syndrome.
The diagnostic criteria for FSS are commonly formulated
by expert committees; examples are the 1994 Centers for
Disease Control and Prevention criteria for chronic fatigue
syndrome [1], the Rome III criteria for irritable bowel
syndrome (and other functional gastrointestinal disorders)* Correspondence: susanne.fischer@uni-marburg.de
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article, unless otherwise stated.[2], and the 1990 and 2010 American College of Rheuma-
tology criteria for fibromyalgia [3,4].
These diagnostic criteria are used in clinical practice and
research settings, where patients are asked about symptoms
(positive criterion), medical records are reviewed, and
physical examinations and laboratory tests are performed
in order to identify medical conditions considered ex-
clusionary for FSS (negative criterion). This two-step
approach, which covers the assessment of both criteria
inherent in the definition of FSS, is considered the gold
standard for diagnosing an FSS. However, epidemiological
research is challenged by the limited feasibility of review-
ing medical records and/or conducting comprehensive
medical examinations, and thus often exclusively relies on
self-reported information. Several ways of diagnosing
FSS have been adopted to deal with this problem: a)
asking patients whether they suffer from a (specific)
FSS (self-reported diagnosis), b) asking patients whether
they have ever received an FSS diagnosis by a physician
(physician diagnosis), or c) providing patients with a list ofntral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/4.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
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criteria, but without an assessment of exclusionary factors
(symptom-based diagnosis). Naturally, the approaches
leading to these outcomes differ in their ability to cover
both the positive and negative criterion of FSS.
It is conceivable from this comparison that the choice
of diagnostic strategy may contribute to diverging study
findings. In fact, reviews on the epidemiology of each FSS
show a broad range of prevalence rates across studies (e.g.,
[5-7]). Another epidemiological estimate rather specific to
research on FSS is the amount of comorbidity among FSS,
i.e., the so-called ‘overlap’. With regard to prevalence
rates, overlap between FSS has been found to vary sub-
stantially [8,9]. Importantly, studies showing high levels
of overlap have led some researchers to propose the
existence of only one FSS [10]. These so-called ‘lumpers’
are opposed by other authors, who insist that there are
several specific syndromes, and these authors are usually
referred to as ‘splitters’ [11]. Thus, the overlap rates can be
considered a key parameter in the so-called ‘one vs. many
debate’. However, direct evidence on the repercussions of
using different diagnostic strategies as a possible reason
for the observed discrepancies in prevalence rates and
overlap is extremely scarce.
To the best of our knowledge, so far, only one study has
directly examined the consequences of using different
diagnostic strategies for FSS. In a recent study conducted
among female FSS patients and matched controls, Warren
and Clauw [12] reported a lack of sensitivity and specifi-
city of physician diagnoses (the above-mentioned option
b) when compared to symptom-based diagnoses (option
c). While we fully agree with the authors’ conclusion that
‘queries of symptoms, not diagnoses, are necessary’ (p. 894
in the same article), we believe that merely asking about
characteristic symptoms (positive criterion) may result in
an overestimation of FSS prevalence (and possibly overlap)
rates. In cases in which a thorough medical examination is
not feasible (such as in the above-mentioned study designs),
we believe it preferable to also obtain self-reported infor-
mation on medical illnesses considered exclusionary for
FSS (negative criterion). In essence, we would argue in
favor of a combination of options b) and c) in determining
FSS diagnoses in epidemiological studies (symptom-and-
exclusion-based strategy).
However, the potential impact of this strategy needs to
be examined. We aimed to extend the findings reported
by Warren and Clauw [12] by comparing two different
diagnostic strategies in 17 different FSS in a large, non-
clinical sample of young adults. The two strategies
were as follows: 1) identifying cases of FSS by means of
presenting a list of symptoms that are based on the
diagnostic criteria (symptom-based strategy), and 2)
additionally asking about medical exclusionary criteria
(symptom-and-exclusion-based strategy). We expectedto find 1) a significant decrease in prevalence rates of
FSS, and 2) a marked decrease in the extent of overlap
between FSS when using the symptom-and-exclusion-
based strategy. We tested these hypotheses as part of a




The recruitment procedure for participants in this study
has been described previously elsewhere [13]. In brief,
German-speaking students from 23 Swiss colleges and
universities were contacted via e-mail through cooperating
school administrators, and asked to participate in a web
survey on physical and mental well-being. All procedures
were in accordance with the ethical standards laid down
in the 1964 Declaration of Helsinki, and the web survey
study design was approved by the ethics committee of the
Canton of Zurich. Written informed consent was obtained
from all participants.
Measurement
We administered a previously developed questionnaire
(Questionnaire on Functional Somatic Syndromes; FFSS;
[14]). The German version of the FFSS is freely available
as a Web supplement to the original article (http://con-
tent.karger.com/ProdukteDB/miscArchiv/000/333/298/
000333298_sm_supplemental_material.pdf ). The FFSS
consists of three different parts which are connected via
several algorithms. In the first part, a screening section
encompassing 52 items on various somatic symptoms
was presented. These items represent cardinal symptoms
of 17 FSS: Tension-type headache and persistent idiopathic
facial pain [15], whiplash-associated disorders (pain of at
least 6 months’ duration that is related to an accident),
temporomandibular disorders [16], globus and functional
chest pain of presumed esophageal origin [17], functional
dyspepsia [18], irritable bowel syndrome [2], chronic low
back pain (lower back pain of at least 6 months’ duration
causing impairment), fibromyalgia syndrome [3], chronic
fatigue syndrome [1], multiple chemical sensitivity [19],
chronic pelvic pain in men [20] and in women (lower ab-
dominal pain of at least 6 months’ duration), premenstrual
syndrome [21] and premenstrual dysphoric disorder
[22], and hyperventilation syndrome [23]. The instruc-
tion was to rate all current symptoms (‘I suffer from the
following complaints:’) according to frequency of occur-
rence (‘never/rarely’, ‘frequently’, ‘almost always/always’).
In addition, the screening part contains dichotomous
questions on functional impairment due to symptoms in
different areas and a categorical item on the duration of
symptoms.
In the second part, if participants reported cardinal
symptoms that were at least ‘frequently’ present and
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case of irritable bowel syndrome), additional questions
based on diagnostic criteria (e.g., Rome III) were pre-
sented. Our questions were based on the most commonly
used diagnostic criteria (all publications containing these
criteria can be found in the previous section for each FSS).
These questions allowed for a detailed understanding of
both cardinal and associated symptoms, symptom course
and fluctuation, functional impairment, and symptom
onset for each FSS. Participants were labelled as having
a ‘symptom-based FSS’ if they met the minimum of re-
quired positive criteria (e.g., recurrent abdominal pain
or discomfort on at least 3 days per month in the last
3 months including changes in bowel movement, with
symptom onset at least 6 months previously).
In the third part, those who fulfilled the positive criteria
of a specific FSS were subsequently surveyed about health
care visits. Importantly, visits related to the previously
diagnosed FSS (but not health care visits in general) were
of interest at this point (e.g., ‘Have you ever visited a
doctor about your abdominal pain/changes in bowel
movement?’). Participants who responded with ‘yes’
were ultimately directed to a list of items addressing
frequent differential diagnoses (‘What diagnosis did
your doctor give you regarding your abdominal pain/
changes in bowel movement?’). These lists were again
based on the diagnostic criteria for each FSS as cited
above. If they reported that no abnormalities had
been detected by their doctor that might account for
their symptoms (e.g., an inflammatory bowel disease),
participants were labelled as having a ‘symptom-and-
exclusion-based FSS’. The FFSS screening part has
good psychometric properties regarding both internal
consistency (Cronbach’s alpha = 0.94) and retest reli-
ability (r = 0.80 – 0.94).
Prevalence rates and overlap estimations of symptom-
and-exclusion-based FSS have already been described in
our previous report [13].
Results
Participants’ characteristics
Our recruitment and data preparation process is visu-
alized in Figure 1. A total number of N = 6’206 partici-
pants visited the website and about 51% of them
finished the survey. After the exclusion of implausible
and incomplete datasets (regarding survey response
duration, gender, and age), N = 3’054 datasets remained
for further analyses. Out of these 3’054 participants,
2’242 (73.4%) were women and 812 (26.6%) were men.
The mean age was 24.6 ± 5.6 (SD) years. Parental
household income was almost uniformly distributed
across nine predefined categories ranging from less than
3’000 to more than 10’000 Swiss Francs per month (equal
intervals across categories).Prevalence of FSS
As illustrated in Figure 1, about one third of our sam-
ple endorsed an FSS when using the symptom-based
strategy. Half of these participants had embarked upon
health care visits because of their symptoms. More
than half of the health care visitors were not offered a
medical explanation for their symptoms and those
were thus labelled symptom-and-exclusion-based FSS
cases. To compare the impact of our two diagnostic
strategies on epidemiological data, we calculated the
prevalence rates of 17 FSS according to both strategies.
We additionally included the health care visitor data
for descriptive purposes. No male participant reported
suffering from chronic pelvic pain and thus this FSS
was excluded from all analyses. The results are illus-
trated in Figure 2. The prevalence rates of the premen-
strual syndrome, premenstrual dysphoric disorder, and
chronic pelvic pain all refer to the female population
only. In accordance with our first hypothesis, we
observed marked decreases in prevalence rates when
using a symptom-and-exclusion-based approach to diag-
nosing FSS.
Overlap between FSS
To evaluate the potential impact of our two diagnostic
strategies on the extent of overlap between FSS, we
counted the number of FSS per person according to
each strategy. The number of symptom-based FSS per
person ranged from one to eight, with 631 (62.2%) par-
ticipants reporting only one, 239 (23.6%) reporting
two, 92 (9.1%) reporting three, 35 (3.5%) reporting
four, 13 (1.3%) reporting five, three (0.2%) reporting
six, and one person (0.1%) reporting eight symptom-
based FSS occurring at the same time. The number of
symptom-and-exclusion-based FSS ranged from one to
four: 227 (78.5%) participants fulfilled criteria for only
one, 49 (17.0%) reported two, 12 (4.2%) reported three,
and one person (0.3%) reported four symptom-and-exclu-
sion-based FSS simultaneously.
We then calculated the number of co-occurring FSS
for each strategy separately. Since premenstrual syn-
drome represents a less severe form of premenstrual
dysphoric disorder, the extent of overlap between these
syndromes was not evaluated. We first looked at each
FSS separately. For instance, within the irritable bowel
syndrome group, most people had one additional FSS,
but some had up to seven additional syndromes. We did
this with every syndrome and computed an average
index. Within the symptom-based FSS group, 9.2 ± 3.6
different co-occurring syndromes (out of 16) were present
on average, whereas individuals with symptom-and-exclu-
sion-based FSS fulfilled criteria for an average amount of
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Figure 1 Recruitment and diagnostic process.
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Summary of study results
In this study, we aimed to evaluate the implications of
considering self-reported information on exclusionary
medical conditions in epidemiological research on FSS.
We compared prevalence rates and overlap of 17 FSS
diagnoses obtained by two different diagnostic strategies: a
symptom-based strategy and a symptom-and-exclusion-
based strategy. We report two findings that are in accord-
ance with our initial hypotheses: First, the use of medical
exclusionary criteria (symptom-and-exclusion-based strat-
egy) led to a marked decrease in prevalence rates of FSS
when compared to the symptom-based strategy. Second,
the use of the symptom-and-exclusion-based strategy
resulted in fewer numbers of individuals who were
affected by multiple FSS at the same time. Moreover, it
also resulted in fewer overlapping syndromes.
Integration and interpretation of study results
This is the first study to directly examine the impact of
adding information on exclusionary medical conditionson the prevalence of FSS. In a recent report, Warren
and Clauw [12] found symptom-based diagnoses to be
superior to physician diagnoses of FSS in terms of sensi-
tivity and specificity. While this is an important finding,
with both diagnostic and clinical implications, the results
of the present study indicate that a symptom-based strategy
might, in turn, overestimate prevalence rates of FSS. This is
most likely due to a participant’s incorrect attribution of a
somatic symptom (e.g., abdominal pain) to a specific FSS
(e.g., irritable bowel syndrome), when, in fact, it is part of
a medical illness (e.g., Crohn’s disease).
Our finding of a marked decrease in prevalence rates of
FSS when considering exclusionary medical conditions is
mirrored by other population-based research adopting the
gold standard procedure, in which patients are first asked
about symptoms (positive criterion), followed by physical
examinations and laboratory testing (negative criterion).
None of these studies explicitly assessed the ramifications
of using different diagnostic strategies; however, their
detailed reporting of patient screening procedures (e.g.,
using flow charts) allows the reader to compare the
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Figure 2 Prevalence rates of symptom-based FSS, health care visitors, and symptom-and-exclusion-based FSS.
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example, before vs. after medical examination by the
study investigators, chronic fatigue syndrome was present
in 555 vs. 43 individuals in a US-based study [24], and
7.5% vs. 1.6% in a French sample were estimated to have
fibromyalgia [25]. Similarly, an in-depth look at the study
by Koloski et al. [26], in which an approach comparable to
our symptom-and-exclusion-based strategy was used in
functional gastrointestinal disorders, reveals a more than
doubled decrease in prevalence rates before vs. after the
exclusion of medical illnesses. This suggests that the useof our symptom-and-exclusion-based strategy ‘mimics’ the
diagnostic pathway of epidemiological gold standard
studies adequately well. For absolute comparisons of
prevalence rates obtained by this strategy with findings
of other studies, the interested reader is referred to a
previously published article by our group [13].
Based on our findings, we further argue that potential
misattribution of somatic symptoms to a specific FSS
(instead of a medical illness) artificially inflates the extent
of overlap between syndromes. Only a small number of
population-based studies have examined overlap between
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hand, two of these studies relied either on physician-based
[27] or on symptom-based [28] diagnoses. Their finding of
a substantial co-occurrence of FSS is in accordance with
our finding of more than nine concomitant syndromes in
our symptom-based FSS group. Interestingly, in one of
these studies, the authors argue that their ‘results support
theories suggesting that medically unexplained conditions
share a common etiology’ [[27]; p. 818]. This study, as well
as our finding of a considerable overlap between symp-
tom-based diagnoses, are therefore in favor of the single
syndrome hypothesis [lumpers’ position; [10]]. On the
other hand, in another study, a symptom-and-exclusion-
based strategy was used for the diagnosis of FSS [30].
After re-analyzing their Swedish Twin Registry data, Kato
et al. reported that only 2.8% of their participants were
characterized by multiple FSS [30]. This percentage is in
line with our finding of 4.5% of participants having at least
three symptom-and-exclusion-based FSS. Based on their
findings, the authors conclude that ‘taken together, over-
laps among the three functional somatic syndromes were
not substantial’ (p. 451). This study, as well as our data
obtained by using the symptom-and-exclusion-based
strategy, thus both lend support to the notion of the
existence of multiple specific FSS instead of one single
syndrome [splitters’ position; [11]]. Taken together, study
findings regarding the overlap between FSS seem to
depend heavily on the selected diagnostic strategy, a
finding which has important conceptual ramifications
(one vs. many debate). Importantly, to answer the ques-
tion of overlap, and whether FSS are all expressions of the
same underlying phenomenon or discrete diagnoses, a
different analysis strategy should be employed [see e.g.,
[31,32]]. This strategy would ideally combine a factor
analysis with latent class analysis. Unfortunately, the
hierarchical, modular structure of the herein used FFSS
prevented the use of this approach in the current data set.
Study strengths and limitations
A strength of our study lies in our access to a large, non-
clinical sample that was free of any healthcare-seeking
bias. Nevertheless, a number of limitations need to be
taken into account when interpreting our results. First,
the present survey was conducted in a student sample,
which cannot be considered representative of the general
population. However, as outlined above, our findings are
in accordance with general population-based studies, indi-
cating potential generalizability at least to some extent.
Second, our strategy of establishing diagnoses of FSS was
dependent on health care visits. This led to a reduction of
our sample size, and could have potentially resulted in an
underestimation of ‘true’ prevalence rates in symptom-
and-exclusion-based FSS. However, accounting for med-
ical exclusionary conditions is very likely to explain a largeproportion of the decrease in prevalence rates, as mirrored
by the fact that in 43.1% of cases, a medical explanation
for patients’ symptoms was provided by a health care
professional. Third, due to the nature of a web-based
data collection approach, we were unable to confirm
our diagnoses through a physical examination or labora-
tory assessment in our participants (gold standard proced-
ure). This might again have led to an underestimation of
‘true’ prevalence rates in symptom-and-exclusion-based
FSS, since patients whose symptoms were caused both by
an FSS and a medical condition were not counted as FSS
cases in this study. In other words, we considered those
individuals having a medical condition that explained their
symptoms on part as non-cases. Also, some of the exclu-
sionary medical conditions might have been incidental,
with the FSS actually causing the symptoms. As illustrated
above, our diagnostic strategy does, however, lead to simi-
lar decreases in prevalence rates compared to those epi-
demiological studies using the gold standard approach.Conclusions
To summarize, we were able to show that including in-
formation on exclusionary medical conditions leads to a
significant decrease in prevalence and overlap rates of
FSS. This may call into question the validity of the findings
of a number of epidemiological studies on FSS. In a next
step, the validity of our symptom-and-exclusion-based
strategy should be checked in FSS patients that were diag-
nosed by the gold standard procedure. Also, comparisons
of prevalence rates as obtained by our approach with
prevalence rates of self-reported and physician diagnoses
would be of interest. Future studies should adopt more
rigorous approaches to the study of FSS, and combine
both the positive and negative criterion inherent in their
definition. This is likely to enhance the clinical benefit
from epidemiological findings on FSS, with the potential
to guide diagnostic and, ultimately, treatment decisions.
Abbreviation
FSS: Functional somatic syndromes.
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